Corporate Governance
International Stem Cell Corporation (ISCO) is a publicly traded biotechnology company with a powerful new stem cell technology called human parthenogenetic activation that promises to significantly advance the field of regenerative medicine.
Andrey Semechkin, PhD., Chief Executive Officer
|
|
Committee Composition
| |
Audit Committee |
Compensation Committee |
Governance Committee |
| |
|
|
|
| Independent Directors |
| Donald Wright |
|
|
|
| Paul Maier |
|
|
|
| Inside Directors |
| Andrey Semechkin, PhD. |
|
|
|
| Russell Kern, PhD. |
|
|
|
|
